Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
InterContinental Hotels
IHG
$23.9B
| $575K | ﹤0.01% |
8,629
+734
| +9% | +$51.8K |
|
3877
Broadwind
BWEN
$93.6M
| $573K | ﹤0.01% |
126,646
+13,209
| +12% | +$64.9K |
|
3878
Dolphin Entertainment
DLPN
$13.3M
| $572K | ﹤0.01% |
30,637
+5,861
| +24% | +$113K |
|
3879
US Gold Corp
USAU
$214M
| $572K | ﹤0.01% |
51,524
+12,371
| +32% | +$138K |
|
|
HAAC
3880
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
| $571K | ﹤0.01% |
+57,066
| New | +$582K |
|
3881
Hallador Energy
HNRG
$670M
| $569K | ﹤0.01% |
211,382
+59,402
| +39% | +$140K |
|
3882
Electromed
ELMD
$337M
| $568K | ﹤0.01% |
50,332
-58,190
| -54% | -$595K |
|
3883
Provident Financial
PROV
$111M
| $567K | ﹤0.01% |
32,845
-33,507
| -50% | -$565K |
|
|
ARC
3884
DELISTED
ARC Document Solutions, Inc.
ARC
| $566K | ﹤0.01% |
263,472
+14,185
| +6% | +$31K |
|
|
BIOC
3885
DELISTED
Biocept, Inc.
BIOC
| $565K | ﹤0.01% |
4,495
+104
| +2% | +$14.1K |
|
|
BBIG
3886
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $564K | ﹤0.01% |
10,511
+5,790
| +123% | +$249K |
|
3887
Biglari Holdings Class A
BH.A
$1.25B
| $561K | ﹤0.01% |
721
-550
| -43% | -$425K |
|
3888
Brookfield Infrastructure Partners
BIP
$19.2B
| $561K | ﹤0.01% |
15,152
+2,936
| +24% | +$106K |
|
|
APRN
3889
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $561K | ﹤0.01% |
10,931
| – | – |
|
|
VRN
3890
DELISTED
Veren
VRN
| $559K | ﹤0.01% |
123,652
| – | – |
|
|
VIVS
3891
VivoSim Labs
VIVS
$1.2M
| $559K | ﹤0.01% |
4,964
+373
| +8% | +$37.5K |
|
|
SCOA
3892
DELISTED
ScION Tech Growth I Class A Ordinary Shares
SCOA
| $559K | ﹤0.01% |
57,249
+28,271
| +98% | +$277K |
|
3893
Climb Global Solutions
CLMB
$500M
| $558K | ﹤0.01% |
89,276
+6,148
| +7% | +$39.7K |
|
3894
FerroAtlántica
GSM
$594M
| $554K | ﹤0.01% |
90,623
-180,156
| -67% | -$841K |
|
3895
United States Antimony
UAMY
$751M
| $554K | ﹤0.01% |
561,175
+34,176
| +6% | +$31.7K |
|
|
FFBW
3896
DELISTED
FFBW, Inc. Common Stock
FFBW
| $554K | ﹤0.01% |
48,628
+1,995
| +4% | +$22.4K |
|
|
WHWK
3897
Whitehawk Therapeutics
WHWK
$190M
| $551K | ﹤0.01% |
21,760
+4,495
| +26% | +$103K |
|
3898
Jakks Pacific
JAKK
$301M
| $549K | ﹤0.01% |
49,911
-25,023
| -33% | -$229K |
|
3899
Janux Therapeutics
JANX
$925M
| $549K | ﹤0.01% |
+22,017
| New | +$490K |
|
3900
J. Jill
JILL
$272M
| $549K | ﹤0.01% |
27,863
+8,534
| +44% | +$118K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.